Tag Archives: Jim Greenwood

San Francisco Chronicle: High Drug Co-Pays Deny Needed Treatments

Jim Greenwood

Today, the San Francisco Chronicle published an op-ed that I wrote on the importance of ensuring access to treatments for debilitating diseases that are saving millions of patients from pain and possible death. Patients rightly expect their health insurance plan to cover the best medicines based on their unique needs, at an out-of-pocket cost that makes these therapies accessible. Insurance companies and their allies, seeking to deflect blame for increased premiums at a time of Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Jim Greenwood in WSJ: Curing Hepatitis C Is Cheaper Than Open-Ended Care

Jim Greenwood

On Friday, a letter from BIO President and CEO Jim Greenwood was published in the Wall Street Journal, arguing that curing hepatitis C is cheaper than the alternative of open ended care. The full text of the letter is below: President and CEO of America’s Health Insurance Plans (HIP) Karen Ignagni’s “Paying for the Thousand-Dollar Pill” (op-ed, Aug. 4) plays down the fact that Sovaldi has been shown to achieve a high cure rate for Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , ,

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Jim Greenwood

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, each year America is better equipped to respond to potential biological, chemical, nuclear and radiological threats, BIO president and CEO Jim Greenwood says in a Roll Call op-ed published today. With recent anthrax and smallpox incidents at CDC and NIH labs,  which fortunately did not lead to any human exposure,  it’s worth taking a look at how we might respond Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Welcome to San Diego!

Jim Greenwood

Welcome to the 2014 BIO International Convention. It has been an exciting and important year for our industry. Since we last met, we have seen record IPOs, important new approvals, exciting scientific advances and hard fought policy victories in Washington, DC and the states. But we all know that accomplishments don’t just happen by luck. They are the result of decades of hard work, long hours and repeated setbacks. So while it’s important to celebrate Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

2014 BIO World Congress: Policy Affecting Advanced Biofuels & Renewable Chemicals

Jim Greenwood

The 2014 BIO World Congress on Industrial Biotechnology kicked off with a much needed policy discussion on the issues facing the industrial biotechnology industry. The exclusive Pre-conference Workshop was called “U.S. Policy Outlook: From the RFS to Tax Reform to Farm Bill Implementation – What Lies Ahead for Advance Biofuels and Renewable Chemicals?”. U.S. advanced biofuels and renewable chemical companies have invested nearly $6 billion over the past 5 years to research and develop projects Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,